Bleakley Financial Group’s Theravance Biopharma TBPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-12,584	Closed	-$141K	–	1023
2023 Q4	$141K	Buy	+12,584	New	+$141K	﹤0.01%	875
2023 Q3	–	Sell	-23,700	Closed	-$245K	–	951
2023 Q2	$245K	Buy	+23,700	New	+$245K	0.01%	782